Immunic acquires 4SC’s immunology portfolio
September 28, 2016Immunic acquires two promising drug development programs with validated targets known to be relevant in various immune and autoimmune diseases…Immunic successfully closes 17.5 million Euro Series A financing round
September 27, 2016Planegg-Martinsried, Germany, September 27, 2016 – Immunic AG (Immunic), a recently formed private start-up biotech company in Planegg-Martinsried near Munich, Germany,…
